Document is current
Any future updates will be listed below
-
Authors
Snyder, Laurie D https://orcid.org/0000-0002-5962-2184
Mosher, Christopher https://orcid.org/0000-0002-8463-1947
Holtze, Colin H
Lancaster, Lisa H https://orcid.org/0000-0001-8465-7357
Flaherty, Kevin R
Noth, Imre
Neely, Megan L
Hellkamp, Anne S
Bender, Shaun
Conoscenti, Craig S
de Andrade, Joao A
Whelan, Timothy PM
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01915511 at ClinicalTrials.govDocuments that mention this clinical trial
Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
https://doi.org/10.1136/bmjresp-2015-000108
Hospitalizations in patients with idiopathic pulmonary fibrosis
https://doi.org/10.1186/s12931-021-01851-4
Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
https://doi.org/10.1186/s12931-021-01921-7
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
https://doi.org/10.1007/s00408-021-00506-x
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
https://doi.org/10.1136/bmjresp-2020-000567
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim (N/A)
- License Information
